Recently, President Trump signed four executive orders related to healthcare.
We can help your practice stay on top of the latest healthcare news, rules, regulations and trends. Subscribe to stay current and up to date on important matters that will impact your practice. (To subscribe to our blog click here).
The four orders are all similarly targeting at reducing drug prices, and improving transparency for healthcare patients in the United States.
A short summary of the orders is as follows:
- The first order requires discounts on insulin and EpiPens to be passed on to patients directly, at federally qualified healthcare centers.
- The second order will allow for the import of FDA-approved drugs from countries where the drug is priced lower.
- The third order states that drug rebates would go directly to patients, in an effort to simplify the system and cut out the middlemen.
- The fourth order states that Medicare will be required to purchase drugs at the same price paid by other economically advanced countries.
The fourth order has received strong oppositions from pharmaceutical executives. President Trump has delayed implementation of the fourth order until August 24, 2020 to provide large pharmaceutical companies a chance to propose alternative solutions.
It will prevent the US from subsidizing the cost of research and development for the country and allow Medicare to negotiate prices.
In our next blog post, we will keep you informed of related issues. To get this important information delivered directly to your mail box, click here to Subscribe.
Do you need help staying current and compliant with the latest laws, rules and regulations? We can help. To contact us about your new government rules and regulations, your practice’s risk assessment, or about your other legal needs: CLICK HERE.